RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

During a recent event hosted by the Make America Healthy Again Institute, Robert F. Kennedy Jr., known for his anti-vaccine stance, unveiled plans aimed at reducing the prescription of antidepressants. His remarks have reignited criticism from mental health professionals who highlight the dangers of his misleading assertions. The event centered around the theme of 'overmedicalization,' with speakers questioning the necessity of antidepressants, particularly among younger populations. They made broad claims, lacking substantial evidence, that many individuals are unnecessarily prescribed SSRIs, a category encompassing well-known medications like Zoloft, Prozac, and Lexapro, utilized for treating various mental health conditions such as depression and anxiety. Kennedy's rhetoric included alarming assertions linking SSRI use to increased violence and even mass shootings, including school incidents. He controversially suggested that children, particularly from marginalized communities, are disproportionately prescribed these medications, advocating for alternative methods of treatment that he claims involve 'reparenting' and agricultural work. Moreover, he has repeatedly stated that stopping antidepressants is more challenging than quitting heroin, a claim that has been thoroughly debunked by mental health experts. Notably, Keith Humphreys, an addiction researcher at Stanford University, has remarked that there is a significant difference in addiction risk between antidepressants and heroin, emphasizing the misinformation surrounding Kennedy's statements. The ongoing backlash against Kennedy's proposals underscores the essential need for accurate dialogue regarding mental health.

Sources : Ars Technica

Published On : May 05, 2026, 19:35

Science
Vision Breakthrough: US Startup Launches Groundbreaking Retina Chip in Europe

Science Corp is poised to introduce a revolutionary retina chip in Europe, designed to restore partial vision for indivi...

Business Today | Jul 25, 2026, 01:00
Vision Breakthrough: US Startup Launches Groundbreaking Retina Chip in Europe
AI
The Rise of AI Distillation: A Controversial Technique Sparks Debate in Tech and Government

In recent discussions, a once-obscure topic in artificial intelligence has surged to the forefront of debates among tech...

CNBC | Jul 25, 2026, 12:15
The Rise of AI Distillation: A Controversial Technique Sparks Debate in Tech and Government
Space
SpaceX Successfully Tests Starship Rocket, Launching New Era of Space Exploration

On Friday evening, SpaceX executed a significant milestone by launching its colossal Starship rocket from its facility i...

CNBC | Jul 25, 2026, 24:10
SpaceX Successfully Tests Starship Rocket, Launching New Era of Space Exploration
Gadgets
OpenAI's Micro Keypad: A Novelty for Coders or Just a Confounding Gadget?

Last week, OpenAI made its debut in the hardware landscape with the launch of Micro, a stylish keypad designed to integr...

TechCrunch | Jul 25, 2026, 24:40
OpenAI's Micro Keypad: A Novelty for Coders or Just a Confounding Gadget?
Computing
Market Turbulence: Four Key Factors Impacting Stocks This Week

This past week has been challenging for the stock market, driven by several significant forces that have created turbule...

CNBC | Jul 25, 2026, 20:05
Market Turbulence: Four Key Factors Impacting Stocks This Week
View All News